1Havinga W. Risk of asthma[J]. Lancet,2001,357:313- 314.
2Valovirta E,jacobsen L,Niggemann B,et al. A 3-year Course of Subcutaneous Specific Immunotherapy Results in Long-term Prevention of Asthma in Children. Ten Year Follow-up on the PAT- Study[J]. J Allergy Clin Immunol,2006,117(3) :721.
3Gafvelin G, Thunberg S, Kronqvist M, et al. Cytokine and antibody responses in birchpollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1[J]. Int Arch Allergy Immunol,2005,138(2):59-66.
4Akdis Muheccel,Akdis Cezmi A. Mechanisms of allergen-specific immunotherapy [J]. J Allergy Clin Immunol, 2007,119 ( 4 ) : 780- 791.
5Abramson MJ,Puy RM,Weiner JM. Allergen immunotherapy for asthma[J]. Cochrane Database Syst Rev,2003,21(4):1186-1188.
